194 Survival Outcomes Following Primary Lung SABR: A Single-Centre Experience
Periasamy, Manivannan Brown, Sean Guglani, Samir Bowden, Caitlin Mark, Frances
Periasamy, Manivannan
Brown, Sean
Guglani, Samir
Bowden, Caitlin
Mark, Frances
Date
2026-02-27
Journal Title
Subject
Type
Conference Abstract
Collections
Abstract
Gloucestershire Royal Hospital (GRH) has been delivering stereotactic ablative radiotherapy (SABR) for primary lung cancer in accordance with UK SABR Consortium guidelines. This audit evaluated survival and disease-control outcomes for patients treated with primary lung SABR at our centre.
Citation
Periasamy M., Bolusani P., Brown S., Guglani S., Bowden C. & Mark F. (2026). Survival Outcomes Following Primary Lung SABR: A Single-Centre Experience. Lung Cancer, 212(Supplement 1), no pagination. https://doi.org/10.1016/j.lungcan.2026.109142